Form D/A — PridCor Therapeutics, LLC
0002074593-26-000003 · filed Jul 6, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Reported offering amount
- $6,045,000
- Reported amount sold
- $0
- Minimum investment
- $20,000
- Investors
- 0
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- PridCor Therapeutics, LLC
- CIK
- 2074593
- Entity
- Limited Liability Company
- Jurisdiction
- ALABAMA
- Year incorporated
- 2025
- Address
- 1837 COMMONS NORTH DRIVE
TUSCALOOSA, AL 35406 - Phone
- 2053660696
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
William L Pridgen · Executive OfficerTuscaloosa, AL Find on LinkedIn ↗
-
Brian Corday · Executive OfficerJohns Creek, GA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗